HKD8.38
0.12%
Hong Kong, Mon, Aug 18 2025
ISIN
BMG210A71016
Symbol
512

Grand Pharmaceutical Stock price

HKD8.38
-1.37 14.05% 1M
+3.66 77.54% 6M
+3.58 74.58% YTD
+3.78 82.17% 1Y
+4.18 99.52% 3Y
+0.78 10.26% 5Y
+6.34 310.78% 10Y
+8.26 6,942.02% 20Y
Hong Kong, Closing price Mon, Aug 18 2025
-0.01 0.12%
ISIN
BMG210A71016
Symbol
512
Industry

Key metrics

Basic
Market capitalization
HKD29.2b
Enterprise Value
HKD30.9b
Net debt
HKD1.7b
Cash
HKD2.8b
Shares outstanding
3.5b
Valuation (TTM | estimate)
P/E
12.0 | 13.5
P/S
2.5 | 2.4
EV/Sales
2.7 | 2.5
EV/FCF
23.8
P/B
1.8
Dividends
DPS
HKD0.26
Yield 1Y | 5Y
3.1% | 3.4%
Growth 1Y | 5Y
0.0% | 22.1%
Payout 1Y | 3Y
37.1% | 36.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HKD11.6b | HKD12.4b
EBITDA
- | HKD2.8b
EBIT
HKD2.3b | HKD2.5b
Net Income
HKD2.5b | HKD2.2b
Free Cash Flow
HKD1.3b
Growth (TTM | estimate)
Revenue
10.6% | 6.6%
EBITDA
- | 2.3%
EBIT
-10.6% | 11.7%
Net Income
31.3% | -11.9%
Free Cash Flow
-32.8%
Margin (TTM | estimate)
Gross
57.9%
EBITDA
- | 22.5%
EBIT
19.6%
Net
21.2% | 17.5%
Free Cash Flow
11.2%
Financial Health
Equity Ratio
65.9%
Return on Equity
15.0%
ROCE
12.4%
ROIC
11.2%
Debt/Equity
0.3
More
EPS
HKD0.7
FCF per Share
HKD0.4
Short interest
-
Employees
12k
Rev per Employee
HKD970.0k
Show more

Is Grand Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Grand Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Grand Pharmaceutical forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Grand Pharmaceutical forecast:

Buy
88%
Hold
13%

Financial data from Grand Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
11,645 11,645
11% 11%
100%
- Direct Costs 4,907 4,907
22% 22%
42%
6,738 6,738
3% 3%
58%
- Selling and Administrative Expenses 4,696 4,696
22% 22%
40%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,284 2,284
11% 11%
20%
Net Profit 2,468 2,468
31% 31%
21%

In millions HKD.

Don't miss a Thing! We will send you all news about Grand Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. The company employs 11,987 full-time employees The firm is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The firm is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The firm's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.

Head office Hong Kong
Employees 11,987
Website www.grandpharma.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today